• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TAAR1 的结构和信号机制使选择性激动剂设计成为可能。

Structural and signaling mechanisms of TAAR1 enabled preferential agonist design.

机构信息

NHC Key Laboratory of Otorhinolaryngology, Qilu hospital and School of Basic Medical Sciences, Shandong University, Jinan, Shandong 250012, China; Advanced Medical Research Institute and Meili Lake Translational Research Park, Shandong University, Jinan, Shandong 250012, China.

NHC Key Laboratory of Otorhinolaryngology, Qilu hospital and School of Basic Medical Sciences, Shandong University, Jinan, Shandong 250012, China.

出版信息

Cell. 2023 Nov 22;186(24):5347-5362.e24. doi: 10.1016/j.cell.2023.10.014. Epub 2023 Nov 13.

DOI:10.1016/j.cell.2023.10.014
PMID:37963465
Abstract

Trace amine-associated receptor 1 (TAAR1) senses a spectrum of endogenous amine-containing metabolites (EAMs) to mediate diverse psychological functions and is useful for schizophrenia treatment without the side effects of catalepsy. Here, we systematically profiled the signaling properties of TAAR1 activation and present nine structures of TAAR1-Gs/Gq in complex with EAMs, clinical drugs, and synthetic compounds. These structures not only revealed the primary amine recognition pocket (PARP) harboring the conserved acidic D for conserved amine recognition and "twin" toggle switch for receptor activation but also elucidated that targeting specific residues in the second binding pocket (SBP) allowed modulation of signaling preference. In addition to traditional drug-induced Gs signaling, Gq activation by EAM or synthetic compounds is beneficial to schizophrenia treatment. Our results provided a structural and signaling framework for molecular recognition by TAAR1, which afforded structural templates and signal clues for TAAR1-targeted candidate compounds design.

摘要

痕量胺相关受体 1(TAAR1)可感知一系列内源性含胺代谢物(EAMs),从而介导多种心理功能,并且在没有僵住副作用的情况下对精神分裂症的治疗有用。在这里,我们系统地分析了 TAAR1 激活的信号特性,并展示了 TAAR1-Gs/Gq 与 EAMs、临床药物和合成化合物结合的九个结构。这些结构不仅揭示了包含保守酸性 D 的主要胺识别口袋(PARP),用于保守胺识别,以及“双”Toggle 开关用于受体激活,而且还阐明了靶向第二结合口袋(SBP)中的特定残基可以调节信号偏好。除了传统的药物诱导的 Gs 信号外,EAM 或合成化合物对 Gq 的激活有益于精神分裂症的治疗。我们的结果为 TAAR1 的分子识别提供了一个结构和信号框架,为 TAAR1 靶向候选化合物设计提供了结构模板和信号线索。

相似文献

1
Structural and signaling mechanisms of TAAR1 enabled preferential agonist design.TAAR1 的结构和信号机制使选择性激动剂设计成为可能。
Cell. 2023 Nov 22;186(24):5347-5362.e24. doi: 10.1016/j.cell.2023.10.014. Epub 2023 Nov 13.
2
Structure-Based Design of Novel G-Protein-Coupled Receptor TAAR1 Agonists as Potential Antipsychotic Drug Candidates.基于结构的新型 G 蛋白偶联受体 TAAR1 激动剂设计,作为有潜力的抗精神病候选药物。
J Med Chem. 2024 Mar 14;67(5):4234-4249. doi: 10.1021/acs.jmedchem.4c00195. Epub 2024 Feb 28.
3
In-vivo pharmacology of Trace-Amine Associated Receptor 1.痕量胺相关受体1的体内药理学
Eur J Pharmacol. 2015 Sep 15;763(Pt B):136-42. doi: 10.1016/j.ejphar.2015.06.026. Epub 2015 Jun 17.
4
Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases.痕量胺相关受体 1:神经精神疾病的多模式治疗靶点。
Expert Opin Ther Targets. 2018 Jun;22(6):513-526. doi: 10.1080/14728222.2018.1480723. Epub 2018 Jun 5.
5
Ligand recognition and G-protein coupling of trace amine receptor TAAR1.痕量胺受体 TAAR1 的配体识别和 G 蛋白偶联。
Nature. 2023 Dec;624(7992):672-681. doi: 10.1038/s41586-023-06804-z. Epub 2023 Nov 7.
6
Recognition of methamphetamine and other amines by trace amine receptor TAAR1.痕量胺受体 TAAR1 识别甲基苯丙胺和其他胺类物质。
Nature. 2023 Dec;624(7992):663-671. doi: 10.1038/s41586-023-06775-1. Epub 2023 Nov 7.
7
TAAR1 as an emerging target for the treatment of psychiatric disorders.TAAR1作为治疗精神疾病的一个新兴靶点。
Pharmacol Ther. 2024 Jan;253:108580. doi: 10.1016/j.pharmthera.2023.108580. Epub 2023 Dec 22.
8
The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor.痕量胺相关受体1激动剂3-碘甲腺原氨酸在5-羟色胺1b受体上诱导偏向性信号传导。
Front Pharmacol. 2018 Mar 12;9:222. doi: 10.3389/fphar.2018.00222. eCollection 2018.
9
Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies.TAAR1 激动剂在精神分裂症中的治疗潜力:来自临床前模型和临床研究的证据。
Int J Mol Sci. 2021 Dec 7;22(24):13185. doi: 10.3390/ijms222413185.
10
Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer's Disease.痕量胺相关受体 1(TAAR1)作为治疗阿尔茨海默病认知功能障碍的新靶点。
Int J Mol Sci. 2022 Jul 15;23(14):7811. doi: 10.3390/ijms23147811.

引用本文的文献

1
Role of Glial Trace Amine Associated Receptor 1 (TAAR1) and Microbiota in Schizophrenia.胶质细胞痕量胺相关受体1(TAAR1)和微生物群在精神分裂症中的作用
Neurochem Res. 2025 Aug 21;50(5):273. doi: 10.1007/s11064-025-04525-5.
2
Structure-based identification of bioactive compounds as trace amine-associated receptor 1 agonists for the therapeutic management of major depressive disorder.基于结构鉴定生物活性化合物作为痕量胺相关受体1激动剂用于重度抑郁症的治疗管理
PLoS One. 2025 Aug 5;20(8):e0327890. doi: 10.1371/journal.pone.0327890. eCollection 2025.
3
Chemosensory Receptors in Vertebrates: Structure and Computational Modeling Insights.
脊椎动物的化学感受器:结构与计算建模见解
Int J Mol Sci. 2025 Jul 10;26(14):6605. doi: 10.3390/ijms26146605.
4
Progress in structure-based drug development targeting chemokine receptors.靶向趋化因子受体的基于结构的药物研发进展。
Front Pharmacol. 2025 Jun 9;16:1603950. doi: 10.3389/fphar.2025.1603950. eCollection 2025.
5
Concurrent loss of the Y chromosome in cancer and T cells impacts outcome.癌症和T细胞中Y染色体的同时缺失会影响预后。
Nature. 2025 Jun 4. doi: 10.1038/s41586-025-09071-2.
6
Deorphanization of Olfactory Trace Amine-Associated Receptors.嗅觉痕量胺相关受体的去孤儿化
Methods Mol Biol. 2025;2915:201-212. doi: 10.1007/978-1-0716-4466-9_14.
7
The effects of loss of Y chromosome on male health.Y染色体缺失对男性健康的影响。
Nat Rev Genet. 2025 May;26(5):320-335. doi: 10.1038/s41576-024-00805-y. Epub 2025 Jan 2.
8
Unlocking the secrets of trace amine-associated receptor 1 agonists: new horizon in neuropsychiatric treatment.揭开痕量胺相关受体1激动剂的秘密:神经精神疾病治疗的新视野。
Front Psychiatry. 2024 Oct 31;15:1464550. doi: 10.3389/fpsyt.2024.1464550. eCollection 2024.
9
Engineered odorant receptors illuminate the basis of odour discrimination.工程化气味受体阐明了气味辨别基础。
Nature. 2024 Nov;635(8038):499-508. doi: 10.1038/s41586-024-08126-0. Epub 2024 Oct 30.
10
The role of the gut microbiota in neurodegenerative diseases targeting metabolism.肠道微生物群在以代谢为靶点的神经退行性疾病中的作用。
Front Neurosci. 2024 Sep 26;18:1432659. doi: 10.3389/fnins.2024.1432659. eCollection 2024.